Environmental control measures for the management of atopy

Annals of Allergy, Asthma & Immunology

February   2017  Volume 118, Issue 2, Pages 154-160   CME Review

Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planning Committee Members:
Meredith Dilley, MD (Author)
Wanda Phipatanakul, MD, MS (Author)
Anne K. Ellis, MD (Associate Editor)
Jonathan A. Bernstein, MD (Annals CME Subcommittee)
Guha Krishnaswamy, MD (Annals CME Subcommittee)
John J. Oppenheimer, MD (Annals CME Subcommittee, Associate Editor)
Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)
Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)

Target Audience

Physicians involved in providing patient care in the field of allergy/asthma/immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:
Define major in-home allergens associated with allergic sensitization
Describe methods of allergen abatement in the home environment specific to each allergen
 

Additional information
Disclosure: 

M. Dilley and W. Phipatanakul have nothing to disclose. M.H. Grayson has received research grants from Children’s Research Institute/Medical College of Wisconsin, Merck, National Institutes of Health (NIH), and Polyphor. G.D. Marshall has received research grants from Amgen, AstraZeneca, HRSA and National Institutes of Health (NIH). J.J. Oppenheimer has been a consultant/advisor for AstraZeneca, GlaxoSmithKline, Meda, Mylan, and Sunovion; has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis. A.K. Ellis has received research grants from Circassia, Sun Pharma Advanced Research, Merck, Novartis, Pfizer, and GlaxoSmithKline; has also been a consultant/advisor for Circassia, Merck, Novartis, and GlaxoSmithKline; and has been a speaker for Merck, Novartis, Takeda and AstraZeneca. J.A. Bernstein, G. Krishnaswamy have nothing to disclose. Reviewers and Education/Editorial staff have no relevant financial relationships to disclose. No unapproved/investigative use of a product/device is discussed.    

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 1.00 MOC
Course opens: 
02/01/2017
Course expires: 
01/31/2018
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
  • 1.00 MOC

Accreditation Period

Course opens: 
02/01/2017
Course expires: 
01/31/2018

Price

Cost:
$0.00
Please login or create an account to take this course.